Fig. 1 · Structure
Documents & Downloads
Tanuxiciclib
CDK Inhibitor
Tanuxiciclib is a selective cyclin-dependent kinase (CDK) inhibitor that targets multiple CDK family members. It exhibits potent antitumor activity through the inhibition of cell cycle progression, making it a valuable tool in cancer research. This compound is utilized in studies investigating cell proliferation, apoptosis, and the mechanisms of cancer cell survival, offering potential insights into novel therapeutic strategies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1983983-64-7 |
| Applications | CDK Inhibitor |
| Formula | C15H13FN6O |
| Molecular Weight | 312.30 |
| SMILES | FC1=C(C2=CC=C(O)C(C3=CC(C)=NC(N)=N3)=N2)C=CN=C1N |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.